Single domain antibodies (sdAbs) target unique epitopes inaccessible by conventional antibodies. Explore the many benefits of sdAbs, such as enhanced tissue penetration, the ability to bind small cavities or clefts, high affinity, specificity, and stability under extreme temperatures or pHs
ProSci offers recombinant single domain antibodies for SARS-CoV-2 Spike S1 and S2.
The S1 antibodies show various preferences to the latest Variants of Concern, Delta and Omicron:
Cat. No. SD9789 against the Spike glycoprotein S2 domain shows cross-reactivity with wild type, delta, and omicron while Cat. No. SD9787 shows a preference for delta:
